BRCA2 and hereditary nonpolyposis colon cancer: The significantly increased risk among those with a hereditary predisposition led members of the International Cancer of the Pancreas Screening (CAPS) Consortium to reach a consensus agreement that first-degree relatives of an affected PC patient from a familial pancreatic cancer kindred, patients with Peutz-Jeghers syndrome and p16, BRCA2, and HNPCC mutation carriers with at least one affected first-degree relative should undergo PC surveillance [5].